Dr. Stanley Schrier's Gift Fund
To learn more about making a gift in Dr. Schrier's memory, click here.
Dr. Steven Coutre’s Gift Fund
To learn more about making a gift in Dr. Coutre's memory click here.
Make a Gift to the Division of Hematology
To learn more about how to make a gift to the division, visit here.
We are seeking a Life Science Research Professional 1 position to work in the world-renowned Kuo lab in cancer research.
Faculty Reimbursement Form
Stanford Faculty can submit their expense reimbursement requests via this link:
Hematology Expense Reimbursement Request Form
All other expense reimbursement requests can be submitted by using the following form:
Travel Reimbursement Guidelines
Travel Reimbursement Video
See Below for other publications
Message from the Interim Chief Dr. Beverly Mitchell
Welcome to the Stanford Division of Hematology, a dynamic center for basic and translational research, clinical trials, patient care, and teaching. Our physicians, scientists, staff, and trainees collaborate to advance the understanding and treatment of hematologic disorders, all with the goal of improving outcomes for patients with these diseases. In pursuit of this objective, we engage with the broader Stanford community to bring innovation to our efforts.
Over the last 20 years, multiple novel therapies have resulted in significant clinical advances for hematologic diseases, and Stanford investigators have played key roles in their development, including imatinib for CML, ibrutinib for CLL, midostaurin for mast cell disease, and many others. Our clinicians have expertise in a broad range of hematologic disorders including acute and chronic leukemias, myeloproliferative neoplasms, myelodysplastic syndromes, multiple myeloma, amyloidosis, thrombotic diseases, coagulation disorders, and general hematology.
The basic and translational research efforts of the division have led to fundamental discoveries in areas as diverse as leukemia & stem cells, genomics, thrombosis, telomere & cancer biology, and the microbiome. Our passionate faculty members have mentored and trained leaders in the field of hematology and are committed to attract the next generation of leading physicians and research scientists. We invite you to learn more about us through our website.
Congratulations Dr. Rondeep Brar Medical Director for Cancer DSL and SCI’s Associate Director for Clinical Care
Rondeep Brar, MD, Named Medical Director for Cancer DSL & SCI’s Assoc. Director for Clinical Care
We are delighted to announce that Rondeep (Roni) Brar, MD, clinical associate professor of Medicine, has been appointed Stanford Health Care’s Medical Director for the Cancer Destination Service Line (DSL) and Stanford Cancer Institute’s Associate Director for Clinical Care. He began in these dual roles on Monday, February 6.
Over the last decade, Dr. Brar has shown tremendous vision in re-imagining and elevating our health system’s inpatient cancer care services and ambulatory hematology practice. This includes engaging with and leading teams to redesign the Advanced Practice Provider (APP) system, improve inpatient documentation, grow patient volumes, and increase and diversify clinical trial enrollments.
These successes are a testament to Dr. Brar’s strong leadership, expansive expertise, cutting-edge clinical research, and compassionate care. They also reflect his vast institutional knowledge and the strong collegial relationships he has formed across Stanford Medicine.
After receiving his MD from UCLA in 2007, Dr. Brar completed his internal medicine residency at Stanford in 2010, and his fellowships in hematology and oncology at Stanford in 2012. Dr. Brar was then recruited as a Clinical Assistant Professor in the Department of Medicine, Division of Hematology in 2012. He was subsequently promoted to Clinical Associate Professor in 2018.
Since August 2021, alongside Heather Wakelee, MD, Dr. Brar has served as the Interim Medical Co-Director of the Cancer DSL. During this time, Drs. Brar and Wakelee have re-aligned the structure and leadership of the Cancer Care Programs, reconfigured the leadership cabinet to represent a broader constituent group, and engaged in strategic planning for our joint ventures and future campus expansion.
Dr. Brar will work closely with Drs. Artandi and Seshadri as well as Maria Gonzalez, Executive Director of the Cancer DSL, to shape and implement the future of the Cancer DSL.
Dr. Wakelee will continue to provide interim support through March 2023 as Dr. Brar transitions some of his clinical operations. We want to thank Dr. Wakelee for her dedication and stellar leadership as she continues her exemplary service as the Division Chief of Medical Oncology and Deputy Director of SCI and for her extensive work in enhancing cancer clinical trials.
We also want to express our gratitude to our search committee and the stakeholders across Stanford Medicine who helped facilitate this important search.
We are excited to have Dr. Brar serve in these leadership roles and look forward to his contributions. Please join us in congratulating Dr. Brar on this well-deserved recognition.
Steve, Sri, and Niraj
National Comprehensive Cancer Network Spotlight on NCCN leaders
NCCN Guidelines Panel Members
Congratulations to Dr. Mannis!
Congradulations Dr. Sydney Lu
The American Society of Hematology (ASH) selected Dr. Sidney Lu for the 2023 ASH Junior Faculty Scholar Award in basic/translational research.
Dr. Lu is part of this prestigious ASH award program.
Congratulations Soumaya Zlitni on being recognized as the JEDI Champion!
Stanford Postdoc JEDI Champion Awards recognize current Stanford University postdoctoral scholars who have championed initiatives, activities, and efforts that advance justice, equity, diversity, and inclusion at Stanford and beyond.
Dr. William Shomali featured in the 2022 Annual Report
William Shomali, MD Hematoligist shares his journey.
Dr. Jason Gotlib featured in the 2022 Annual report
Dr. Jason Gotlib, MD, MS Clinical Trialist shares his passion for photography and clinical studies in Hematology.
Dr. May Chien featured in the 2022 Annual Report
Dr. May Chien, MD shares on becoming a Classical Hematologist
Bhuvana Ramachandran, Hematology Administrator shares what it take to run a Division.
The faculty retreat was held on Aug 20, 2022 to discuss various strategic initiatives. We also welcomed our Interim Chief, Dr. Beverly Mitchell, who will be leading the division from Sep 1, 2022. Thank you all for your presentations, discussions, and ideas that we plan to implement in the future!
Congradulations Dr. Mannis
Dr. Gabe Mannis is the recipient of the Department of Medicine Teaching Award for 2021. He was honored in an award ceremony on Nov 2, 2022 at the LKSC Berg Hall.
Halloween Fun at MED8
The Med 8 Team celebrated Halloween in true Hematology fashion, with “costumes” of various blood cells - Neutrophil, B cell, Eosinophil, Natural Killer Cell, and CD4 T cell. Thanks to Mike Glover who organized this fun costume!
Welcome New Faculty
Congratulations to the Hematology/Oncology Fellowship Leadership Team and Admin Team!
SHC once again named on U.S. News & World Report's "Best Hospitals" Honor Roll
Stanford Cancer Care jumped from 21st to 12th!
Stanford Health Care (SHC) has once more been named one of the country's top hospitals. Notably, Stanford Health Care achieved national acclaim in Cancer among other areas in the domains of safety, quality of care, patient experience, and patient outcomes. Stanford's Cancer Care had a remarkable jump from 21st to 12th!
Overall, Stanford Hospital's national ranking rose to 12th, ranking 4th in California and 1st in the San Jose metropolitan area. Special thanks to our Hematology and Oncology Physicians and SHC for this remarkable performance!
Resident Research Retreat April 2021 with Dr. Chien and Dr. Mannis
Congratulations to Dr. Dunn on her promotion to Associate Professor!
Thank you for your amazing contribution as Program Director of the Hem-Onc Fellowship and to the Department of Medicine’s DEI efforts as Associate Chair, Diversity and Inclusion.
The Steven Coutre Review of the 64th Annual American Society of Hematology Meeting was well attended by those who study in the field on Saturday, February 11, 2023 in Half Moon Bay, CA. Those that attended were fellows, residents specialist in Hematology and Oncology.
Subscribe to our newsletter by emailing email@example.com
Dr. Tamara Dunn was featured on the CBS morning news on Friday, January 22, 2021 as she was speaking on the importance of getting the COVID-19 vaccine.